Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Schedule of Allocated Stock-based Compensation Expense

The following table sets forth the allocation of the Company’s stock-based compensation expense in the consolidated statements of operations and comprehensive income for the three and six months ended June 30, 2020 and 2019:

	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2020		2019		2020		2019
Sales and marketing	$	129	$	106	$	253	$	177
Product development and content	1,741		1,643		3,669		3,142
General and administrative	980		1,116		2,113		1,971
Total stock-based compensation expense	$	2,850	$	2,865	$	6,035	$	5,290

Schedule of Stock Option Activity

The following table sets forth the Company’s stock options activity for the six months ended June 30, 2020:

(in thousands, except share and per share data) Stock Options	Number of Stock Options		Weighted-average Exercise Price		Weighted-average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Outstanding as of January 1, 2020	3,680,146		$	3.60
Exercised	(506,105	)	3.98
Forfeited or expired	(85,000	)	3.65
Outstanding as of June 30, 2020	3,089,041		$	3.54	4.4	$	8,257
Exercisable as of June 30, 2020	3,053,207		$	3.55	4.4	$	8,125

Schedule of RSA Activity

The following table sets forth the Company’s RSAs activity for the six months ended June 30, 2020:

	Number of
	Restricted Stock		Weighted-average
Restricted Stock Awards	Awards		Stock Price
Outstanding as of January 1, 2020	4,036,398		$	4.85
Granted	620,277		5.51
Vested	(1,648,692	)	4.85
Forfeited or expired	(120,137	)	5.54
Outstanding as of June 30, 2020	2,887,846		$	4.95

Schedule of PSU Activity

The following table sets forth the Company’s PSUs activity for the six months ended June 30, 2020:

	Number of
	Performance Share	Weighted-average
Performance Share Units	Units	Stock Price
Outstanding as of January 1, 2020	1,086,100	$	4.34
Granted	60,000	6.61
Outstanding as of June 30, 2020	1,146,100	$	4.46